Furthermore, due to its ability to provide a plethora of metabolites to sustain metabolism, autophagy may mitigate the antitumor effects of diverse metabolic inhibitors, suggesting that the susceptibility of BC cells with genetically engineered or mTOR-induced autophagy defects might extend beyond metabolic drugs targeting glycolysis or mitochondrial ETC.89 Here, MTOR is linked to breast cancer.